Title : Preclinical evaluation of properties of a new targeted cytotoxic somatostatin analog, AN-162 (AEZS-124), and its effects on tumor growth inhibition - Seitz_2009_Anticancer.Drugs_20_553 |
Author(s) : Seitz S , Schally AV , Treszl A , Papadia A , Rick F , Szalontay L , Szepeshazi K , Ortmann O , Halmos G , Hohla F , Buchholz S |
Ref : Anticancer Drugs , 20 :553 , 2009 |
Abstract : |
PubMedSearch : Seitz_2009_Anticancer.Drugs_20_553 |
PubMedID: 19491659 |
Title : Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies - Nagy_2000_Proc.Natl.Acad.Sci.U.S.A_97_829 |
Author(s) : Nagy A , Plonowski A , Schally AV |
Ref : Proceedings of the National Academy of Sciences of the United States of America , 97 :829 , 2000 |
Abstract : |
PubMedSearch : Nagy_2000_Proc.Natl.Acad.Sci.U.S.A_97_829 |
PubMedID: 10639165 |